Short interest in Prelude Therapeutics Inc (NASDAQ:PRLD) decreased during the last reporting period, falling from 3.38M to 3.12M. This put 17.98% of the company's publicly available shares short.

Short interest for Prelude Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Prelude Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 273.91K shares traded per day, it would take 11.38 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.